Tadalafil Tablet, Film Coated
Product Images NDC 72789-324

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 72789-324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (72789324)

Image (72789324)
This is a bottle of medication containing 90 tablets of Tadalafil in 5mg dosage. The manufacturer is Pharmaceutical Incorporated in Oklahoma City, OK and the National Drug Code (NDC) is 72789-324-90. The tablets are USP certified. The medication is meant to be taken as per doctor's prescription and it is advised to contact a doctor in case of side-effects. The bottle has a Lot# E23D50 with an expiration date of 01/2026.*
FDA Label Image

Chemical Structure (Tadalafil 1)

FDA Label Image

Tadalafil-tablets-figure-1 (Tadalafil 2)

Tadalafil-tablets-figure-1 (Tadalafil 2)
This is a chart showing the difference in blood pressure (measured in mmHg) between the drug Tadalafil and a placebo. It includes readings for standing systolic and diastolic blood pressure, as well as supine systolic and diastolic blood pressure. The chart is also divided by time in hours.*
FDA Label Image

Tadalafil-tablets-figure-2 (Tadalafil 3)

FDA Label Image

Tadalafil-tablets-figure-3 (Tadalafil 4)

Tadalafil-tablets-figure-3 (Tadalafil 4)
This is a chart showing the systolic blood pressure (measured in mmHg) at various time points after administration of different doses of a medication called tadalafil and a medication called doxazosin. The different treatment groups are labeled as 20 mg tadalafil & 8 mg qd doxazosin, placebo & 8 mg qd doxazosin, 20 mg tadalafil (20:00) & 8 mg qd doxazosin (08:00), and placebo (20:00) & 8 mg qd doxazosin (08:00).*
FDA Label Image

Tadalafil-tablets-figure-4 (Tadalafil 5)

FDA Label Image

Table 5 (Tadalafil 6)

FDA Label Image

Table 6 (Tadalafil 7)

Table 6 (Tadalafil 7)
The text refers to a comparison of the change in IPSS Total Score between a group receiving Tadalafil 5 mg and a Placebo group. No additional information is available.*
FDA Label Image

Tadalafil-tablets-figure-7 (Tadalafil 8)

FDA Label Image

Image 8 (Tadalafil 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.